Search

Piraye Y Beim

from New York, NY
Age ~45
Get Report
Also known as:
Piraye Yurttas, Pipay Yurttas, E Yurttas
Related to:
Yurttas Lale, 72Brittany M Beim, 31Riley B Beim, 27Emre Yurttas, 34Nicholas F Beim, 54Lale L Yurttas, 72Salih Yuttas, 75Elizabeth A Beim, 84David O Beim, 84
Connected to:
Arthur L Beimborn, 103Beverly A Beimdiek, 62Daniel D Beimel, 65Katherine A Beimesche, 79Alison Beimfohr, 49Kristen A Beimfohr, 32Rita M Beimfohr, 55Taylor R Beimfohr, 30Cassondra J Beimler, 33Alfred Beimonte, 54

Piraye Beim Phones & Addresses

  • New York, NY
  • College Station, TX
  • Union City, NJ
  • Ithaca, NY

Work

Company: Celmatix, inc. 2012 Address: Greater New York City Area Position: Founder, director, and chief executive officer

Education

Degree: PhD School / High School: Cornell University 2001 to 2007 Specialities: Molecular Biology/Mammalian Embryology

Skills

Biotechnology • Molecular Biology • Genetics • Lifesciences • Cell Culture • Laboratory • Cell • Biochemistry • Research • Life Sciences • Genomics • Science • Biomarkers • Cell Biology • Proteomics • Bioinformatics • Clinical Research • Computational Biology • Pcr • Western Blotting

Industries

Biotechnology

Resumes

Resumes

Piraye Beim Photo 1

Healthcare Innovators Fellow

View page
Location:
New York, NY
Industry:
Biotechnology
Work:
Celmatix, Inc. - Greater New York City Area since 2012
Founder, Director, and Chief Executive Officer
Celmatix, Inc. - Greater New York City Area 2009 - Jul 2012
Founder and Chief Scientific Officer
University of Cambridge 2008 - 2009
Post-doctoral Research Associate
Weill Cornell Medical College 2001 - 2008
Graduate Student
Education:
Cornell University 2001 - 2007
PhD, Molecular Biology/Mammalian Embryology The University of Texas at Austin 1996 - 2001
B.S./B.A., Biology, Plan II Université Paul Sabatier (Toulouse III) 1998 - 1999
Skills:
Biotechnology
Molecular Biology
Genetics
Lifesciences
Cell Culture
Laboratory
Cell
Biochemistry
Research
Life Sciences
Genomics
Science
Biomarkers
Cell Biology
Proteomics
Bioinformatics
Clinical Research
Computational Biology
Pcr
Western Blotting

Business Records

Name / Title
Company / Classification
Phones & Addresses
Piraye Yurttas Beim
President
Celmatix Inc
1 Little West 12 St, New York, NY 10014
60 State St, Boston, MA 02109
Piraye Beim
Celmatix
Biotechnology
54 W 40 St, New York, NY 10018

Publications

Us Patents

Methods And Devices For Assessing Risk To A Putative Offspring Of Developing A Condition

View page
US Patent:
20130109583, May 2, 2013
Filed:
Oct 2, 2012
Appl. No.:
13/633765
Inventors:
Piraye Yurttas Beim - New York NY, US
International Classification:
C12Q 1/68
US Classification:
506 9
Abstract:
The invention generally relates to methods and devices for assessing risk to a putative offspring of developing a condition. In certain embodiments, the invention provides methods for assessing risk to a putative offspring of developing a condition that involve obtaining a maternal sample, conducting an assay on at least one infertility-associated biomarker, and assessing risk to a putative offspring of developing a condition based upon results of the assay.

Methods And Systems For Assessing Infertility As A Result Of Declining Ovarian Reserve And Function

View page
US Patent:
20200340059, Oct 29, 2020
Filed:
Nov 9, 2019
Appl. No.:
16/679185
Inventors:
- New York NY, US
Piraye Yurttas BEIM - New York NY, US
International Classification:
C12Q 1/6883
G16B 40/00
A61K 31/138
A61K 31/566
Abstract:
The present invention relates to methods and systems for assessing ovarian reserve and function in a female subject and informing course of treatment thereof. The invention provides methods for assessing ovarian reserve and function by analyzing both clinical and genetic data/characteristics from a female subject. These methods involve the determination of the presence of one or more mutations in a gene, the gene being associated with fertility and/or ovarian reserve or function. In certain aspects the methods also involve the determination of one or more clinical characteristics associated with fertility and/or ovarian reserve or function. In certain embodiments, the clinical and genetic characteristics obtained from a female subject can be used as data to be input to an ovarian reserve predictor, such that a probability of the female subject suffering from ovarian reserve dysfunction or premature decline can be generated.

Systems And Methods For Determining The Probability Of A Pregnancy At A Selected Point In Time

View page
US Patent:
20190252043, Aug 15, 2019
Filed:
Apr 26, 2019
Appl. No.:
16/395989
Inventors:
- New York NY, US
Hrishikesh KARVIR - Hamilton NJ, US
Piraye Yurttas BEIM - New York NY, US
International Classification:
G16B 40/00
G16B 20/00
Abstract:
The present invention generally relates to systems and methods for determining the probability of a pregnancy at a selected point in time. Systems and methods of the invention employ an algorithm that has been trained on a reference set of data from a plurality of women for whom at least one of fertility-associated phenotypic traits, fertility-associated medical interventions, or pregnancy outcomes are known, in which the algorithm accounts for any woman who ceases pregnancy attempts prior to reaching a live birth outcome.

Methods For Assessing The Potential For Reproductive Success And Informing Treatment Therefrom

View page
US Patent:
20190080800, Mar 14, 2019
Filed:
Apr 5, 2018
Appl. No.:
15/946488
Inventors:
- New York NY, US
Piraye Yurttas Beim - New York NY, US
International Classification:
G16H 50/30
G01N 33/569
G01N 33/50
G16H 10/60
Abstract:
The invention provides methods for analyzing a patient's potential for achieving ongoing pregnancy with respect to a specific fertility treatment. The methods involve obtaining a sample containing microorganisms from an individual, identifying a number of specific microorganisms present in an individual, and comparing these microorganisms to those known to be associated with reproductive success. The individual is then informed of her or his potential reproductive success based upon the results of the comparison.

Method For Assessing Fertility Based On Male And Female Genetic And Phenotypic Data

View page
US Patent:
20170351806, Dec 7, 2017
Filed:
May 31, 2017
Appl. No.:
15/610058
Inventors:
- New York NY, US
Piraye Yurttas Beim - New York NY, US
International Classification:
G06F 19/18
C12Q 1/68
Abstract:
The present invention generally relates to systems and methods for assessing female fertility and infertility, male fertility and infertility and the combined fertility profile of a male and a female. Systems and methods of the invention determine the fertility potential of a female and a male combined by conducting an assay on a sample obtained from the male and female to determine the presence of one or more fertility-associated genetic variants, obtain fertility-associated phenotypic and/or environmental data from the male and the female, accepting as input data, the genetic variants determined from the female and male and phenotypic and/or environmental exposure data from the male and female, analyze the input data using a prognosis predictor correlated with fertility, and generate a fertility profile that reflects the fertility potential of the male and the female combined by using the prognosis predictor on the input data.

Methods And Systems For Assessing Infertility As A Result Of Declining Ovarian Reserve And Function

View page
US Patent:
20170107573, Apr 20, 2017
Filed:
Oct 19, 2016
Appl. No.:
15/298203
Inventors:
- New York NY, US
Piraye Yurttas Beim - New York NY, US
International Classification:
C12Q 1/68
A61K 31/138
G06F 19/24
A61K 31/566
Abstract:
The present invention relates to methods and systems for assessing ovarian reserve and function in a female subject and informing course of treatment thereof. The invention provides methods for assessing ovarian reserve and function by analyzing both clinical and genetic data/characteristics from a female subject. These methods involve the determination of the presence of one or more mutations in a gene, the gene being associated with fertility and/or ovarian reserve or function. In certain aspects the methods also involve the determination of one or more clinical characteristics associated with fertility and/or ovarian reserve or function. In certain embodiments, the clinical and genetic characteristics obtained from a female subject can be used as data to be input to an ovarian reserve predictor, such that a probability of the female subject suffering from ovarian reserve dysfunction or premature decline can be generated.

Methods And Systems For Endometrial Treatment

View page
US Patent:
20170014456, Jan 19, 2017
Filed:
Jul 13, 2016
Appl. No.:
15/209357
Inventors:
- New York NY, US
Piraye Yurttas Beim - New York NY, US
International Classification:
A61K 35/48
C12N 5/071
C12N 15/90
A61K 9/00
Abstract:
Methods of treating endometrial dysfunction are described including retrieval of endometrial cells including endometrial stem cells from a fertile donor and transplantation of endometrial cells or tissue into a host suffering from endometrial dysfunction. In certain embodiments, methods include genetic modification, tissue culturing, or cryopreservation of the endometrial cells prior to transplantation. In various aspects, endometrial cells are retrieved from an individual during peak fertility and banked for autologous transplantation at a later time.

Systems And Methods For Determining The Probability Of A Pregnancy At A Selected Point In Time

View page
US Patent:
20160078172, Mar 17, 2016
Filed:
Sep 18, 2015
Appl. No.:
14/858540
Inventors:
- New York NY, US
Hrishikesh Karvir - Hamilton NJ, US
Piraye Yurttas Beim - New York NY, US
International Classification:
G06F 19/24
Abstract:
The present invention generally relates to systems and methods for determining the probability of a pregnancy at a selected point in time. Systems and methods of the invention employ an algorithm that has been trained on a reference set of data from a plurality of women for whom at least one of fertility-associated phenotypic traits, fertility-associated medical interventions, or pregnancy outcomes are known, in which the algorithm accounts for any woman who ceases pregnancy attempts prior to reaching a live birth outcome.
Control profile
Piraye Y Beim from New York, NY, age ~45 Get Report